88 related articles for article (PubMed ID: 21906585)
1. Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients.
Ma SG; Xu W; Wei CL; Wu XJ; Hong B; Wang ZJ; Hao HR; Guo HQ
Clin Biochem; 2011 Nov; 44(16):1299-303. PubMed ID: 21906585
[TBL] [Abstract][Full Text] [Related]
2. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
Hjortshøj S; Kristensen SR; Ravkilde J
Am J Emerg Med; 2010 Feb; 28(2):170-6. PubMed ID: 20159386
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
[TBL] [Abstract][Full Text] [Related]
5. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.
Lee YW; Kim HJ; Cho YH; Shin HB; Choi TY; Lee YK
Clin Chim Acta; 2007 Sep; 384(1-2):24-7. PubMed ID: 17570353
[TBL] [Abstract][Full Text] [Related]
6. [Changes of plasma total homocysteine in type I diabetic patients its association with diabetic vascular complications].
Yu TT; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):980-4. PubMed ID: 19253841
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-modified albumin predicts mortality in ESRD.
Sharma R; Gaze DC; Pellerin D; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
Am J Kidney Dis; 2006 Mar; 47(3):493-502. PubMed ID: 16490629
[TBL] [Abstract][Full Text] [Related]
8. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
[TBL] [Abstract][Full Text] [Related]
9. Ischemia-modified albumin in acute stroke.
Abboud H; Labreuche J; Meseguer E; Lavallee PC; Simon O; Olivot JM; Mazighi M; Dehoux M; Benessiano J; Steg PG; Amarenco P
Cerebrovasc Dis; 2007; 23(2-3):216-20. PubMed ID: 17143006
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-modified albumin levels in cerebrovascular accidents.
Gunduz A; Turedi S; Mentese A; Altunayoglu V; Turan I; Karahan SC; Topbas M; Aydin M; Eraydin I; Akcan B
Am J Emerg Med; 2008 Oct; 26(8):874-8. PubMed ID: 18926343
[TBL] [Abstract][Full Text] [Related]
11. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
12. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
[TBL] [Abstract][Full Text] [Related]
13. Ischemia modified albumin, a marker of acute ischemic events: a pilot study.
Talwalkar SS; Bon Homme M; Miller JJ; Elin RJ
Ann Clin Lab Sci; 2008; 38(2):132-7. PubMed ID: 18469358
[TBL] [Abstract][Full Text] [Related]
14. Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice?
Kim JS; Hwang HJ; Ko YG; Kim JS; Choi D; Ha JW; Hong MK; Jang Y
Cardiology; 2010; 116(2):123-9. PubMed ID: 20588021
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-modified albumin concentrations should be interpreted with caution in patients with low serum albumin concentrations.
Gaze DC; Crompton L; Collinson P
Med Princ Pract; 2006; 15(4):322-4. PubMed ID: 16763404
[TBL] [Abstract][Full Text] [Related]
16. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses.
Ipcioglu OM; Ozcan O; Gultepe M; Ates A; Basoglu C; Cakir E
Clin Biochem; 2008 Jul; 41(10-11):831-5. PubMed ID: 18457673
[TBL] [Abstract][Full Text] [Related]
17. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
[TBL] [Abstract][Full Text] [Related]
18. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
19. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
20. Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families.
Grassi M; Kisialiou A; Assanelli D; Mozzini C; Archetti S; Pezzini A
Hum Hered; 2008; 66(1):50-60. PubMed ID: 18223316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
